Sumatriptan needle-free injection

Drug Profile

Sumatriptan needle-free injection

Alternative Names: Needle-free subcutaneous sumatriptan; Sumatriptan DosePro®; Sumatriptan Intraject®; Sumavel DosePro

Latest Information Update: 04 Jun 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Zogenix
  • Developer Desitin Pharmaceuticals GmbH; Zogenix
  • Class Antimigraines; Indoles; Small molecules; Sulfonamides; Tryptamines
  • Mechanism of Action Serotonin 1D receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Migraine

Most Recent Events

  • 20 May 2015 Launched for Migraine in Lebanon (SC) before May 2015
  • 31 Dec 2014 Launched for Migraine in Israel (SC) before December 2014
  • 31 Dec 2014 Launched for Migraine in USA (SC, 4mg) before December 2014
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top